TG Therapeutics Inc (TGTX)
13.72
-0.18
(-1.33%)
USD |
NASDAQ |
Apr 26, 11:00
TG Therapeutics Price: 13.72 for April 26, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 25, 2024 | 13.56 | 13.99 | 13.29 | 13.91 | 3.854M |
| Apr 24, 2024 | 14.28 | 14.35 | 13.74 | 13.98 | 2.725M |
| Apr 23, 2024 | 14.17 | 14.56 | 14.17 | 14.25 | 3.223M |
| Apr 22, 2024 | 13.95 | 14.31 | 13.66 | 14.10 | 2.274M |
| Apr 19, 2024 | 13.87 | 14.02 | 13.26 | 13.78 | 3.666M |
| Apr 18, 2024 | 13.99 | 14.63 | 13.85 | 13.99 | 3.484M |
| Apr 17, 2024 | 14.06 | 14.14 | 13.55 | 13.82 | 3.077M |
| Apr 16, 2024 | 13.98 | 14.17 | 13.76 | 14.00 | 1.615M |
| Apr 15, 2024 | 14.15 | 14.58 | 13.94 | 14.07 | 2.269M |
| Apr 12, 2024 | 14.76 | 14.87 | 13.91 | 14.16 | 3.881M |
| Apr 11, 2024 | 14.81 | 14.99 | 14.58 | 14.76 | 2.242M |
| Apr 10, 2024 | 14.56 | 15.06 | 14.44 | 14.71 | 2.985M |
| Apr 09, 2024 | 15.16 | 15.37 | 14.98 | 15.10 | 1.943M |
| Apr 08, 2024 | 14.62 | 15.03 | 14.31 | 14.97 | 2.003M |
| Apr 05, 2024 | 14.36 | 14.64 | 14.19 | 14.52 | 2.300M |
| Apr 04, 2024 | 14.65 | 14.88 | 14.38 | 14.46 | 2.635M |
| Apr 03, 2024 | 14.39 | 14.59 | 14.04 | 14.47 | 2.290M |
| Apr 02, 2024 | 14.43 | 14.59 | 14.13 | 14.44 | 2.768M |
| Apr 01, 2024 | 15.13 | 15.18 | 14.65 | 14.77 | 2.220M |
| Mar 28, 2024 | 15.56 | 15.60 | 15.14 | 15.21 | 2.328M |
| Mar 27, 2024 | 15.55 | 15.62 | 15.06 | 15.57 | 1.455M |
| Mar 26, 2024 | 15.83 | 15.99 | 15.24 | 15.44 | 2.651M |
| Mar 25, 2024 | 15.46 | 15.82 | 15.40 | 15.69 | 1.771M |
| Mar 22, 2024 | 15.24 | 15.76 | 15.03 | 15.49 | 2.045M |
| Mar 21, 2024 | 15.55 | 15.79 | 15.10 | 15.25 | 2.156M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.74
Minimum
Jun 16 2022
54.90
Maximum
Dec 21 2020
18.36
Average
14.78
Median
Price Benchmarks
| Amicus Therapeutics Inc | 10.26 |
| Geron Corp | 3.765 |
| Editas Medicine Inc | 5.29 |
| G1 Therapeutics Inc | 3.965 |
| Mersana Therapeutics Inc | 2.835 |
Price Related Metrics
| PE Ratio | 1372.50 |
| PS Ratio | 8.721 |
| Price to Book Value | 13.21 |
| Earnings Yield | 0.07% |
| Market Cap | 2.119B |
| Operating PE Ratio | 98.76 |
| Normalized PE Ratio | 1372.50 |